Amoy Diagnostics Co Ltd
SZSE:300685
Amoy Diagnostics Co Ltd
SZSE:300685
Price:
20.12
CNY
-12.1%
Market Closed
Market Cap:
7.9B
CNY
Income Statement
Earnings Waterfall
Amoy Diagnostics Co Ltd
Amoy Diagnostics Co Ltd
|
Revenue
|
1.2B
CNY
|
|
Cost of Revenue
|
-186.1m
CNY
|
|
Gross Profit
|
997.8m
CNY
|
|
Operating Expenses
|
-659.6m
CNY
|
|
Operating Income
|
338.2m
CNY
|
|
Other Expenses
|
-23.2m
CNY
|
|
Net Income
|
315m
CNY
|
Income Statement
Amoy Diagnostics Co Ltd
Amoy Diagnostics Co Ltd
Currency: CNY
Millions
TTM
| Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||
| Revenue |
288
N/A
|
315
+9%
|
330
+5%
|
357
+8%
|
384
+8%
|
398
+4%
|
439
+10%
|
469
+7%
|
502
+7%
|
541
+8%
|
578
+7%
|
550
-5%
|
596
+8%
|
650
+9%
|
728
+12%
|
812
+11%
|
844
+4%
|
890
+5%
|
917
+3%
|
949
+4%
|
911
-4%
|
871
-4%
|
842
-3%
|
831
-1%
|
908
+9%
|
951
+5%
|
1 044
+10%
|
1 082
+4%
|
1 128
+4%
|
1 184
+5%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||
| Cost of Revenue |
(25)
|
(27)
|
(25)
|
(30)
|
(34)
|
(36)
|
(39)
|
(46)
|
(51)
|
(56)
|
(56)
|
(60)
|
(68)
|
(80)
|
(95)
|
(117)
|
(127)
|
(142)
|
(143)
|
(152)
|
(151)
|
(144)
|
(148)
|
(148)
|
(161)
|
(168)
|
(167)
|
(177)
|
(178)
|
(186)
|
|
| Gross Profit |
263
N/A
|
287
+9%
|
305
+6%
|
327
+7%
|
350
+7%
|
362
+3%
|
400
+10%
|
423
+6%
|
452
+7%
|
485
+7%
|
523
+8%
|
490
-6%
|
528
+8%
|
570
+8%
|
633
+11%
|
694
+10%
|
717
+3%
|
748
+4%
|
774
+3%
|
798
+3%
|
759
-5%
|
727
-4%
|
694
-4%
|
683
-2%
|
748
+9%
|
783
+5%
|
876
+12%
|
905
+3%
|
950
+5%
|
998
+5%
|
|
| Operating Income | |||||||||||||||||||||||||||||||
| Operating Expenses |
(190)
|
(197)
|
(197)
|
(205)
|
(216)
|
(230)
|
(267)
|
(279)
|
(306)
|
(331)
|
(370)
|
(350)
|
(371)
|
(391)
|
(425)
|
(461)
|
(470)
|
(490)
|
(520)
|
(536)
|
(545)
|
(544)
|
(534)
|
(515)
|
(550)
|
(570)
|
(585)
|
(623)
|
(650)
|
(660)
|
|
| Selling, General & Administrative |
(191)
|
(200)
|
(152)
|
(172)
|
(187)
|
(178)
|
(195)
|
(232)
|
(239)
|
(261)
|
(289)
|
(285)
|
(292)
|
(308)
|
(333)
|
(356)
|
(364)
|
(373)
|
(367)
|
(392)
|
(397)
|
(400)
|
(357)
|
(371)
|
(392)
|
(391)
|
(382)
|
(412)
|
(426)
|
(436)
|
|
| Research & Development |
0
|
0
|
(45)
|
0
|
0
|
(74)
|
(70)
|
(65)
|
(86)
|
(87)
|
(81)
|
(96)
|
(106)
|
(115)
|
(101)
|
(127)
|
(130)
|
(138)
|
(141)
|
(162)
|
(166)
|
(168)
|
(156)
|
(173)
|
(189)
|
(204)
|
(177)
|
(215)
|
(218)
|
(217)
|
|
| Depreciation & Amortization |
0
|
0
|
(14)
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
(21)
|
0
|
0
|
0
|
(24)
|
0
|
0
|
0
|
(32)
|
0
|
0
|
0
|
(41)
|
0
|
0
|
0
|
(48)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
1
|
2
|
14
|
(33)
|
(29)
|
23
|
15
|
18
|
19
|
19
|
22
|
30
|
27
|
32
|
33
|
22
|
25
|
22
|
19
|
19
|
18
|
24
|
20
|
29
|
30
|
24
|
23
|
4
|
(6)
|
(7)
|
|
| Operating Income |
73
N/A
|
90
+23%
|
109
+21%
|
122
+12%
|
134
+10%
|
132
-2%
|
133
+1%
|
145
+9%
|
146
+1%
|
154
+6%
|
153
-1%
|
140
-9%
|
157
+12%
|
179
+14%
|
209
+17%
|
234
+12%
|
247
+6%
|
259
+5%
|
254
-2%
|
262
+3%
|
214
-18%
|
182
-15%
|
161
-12%
|
168
+5%
|
198
+17%
|
213
+8%
|
292
+37%
|
282
-3%
|
300
+6%
|
338
+13%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||
| Interest Income Expense |
10
|
(1)
|
(2)
|
(4)
|
5
|
11
|
11
|
12
|
9
|
8
|
9
|
15
|
10
|
(0)
|
(7)
|
(12)
|
(12)
|
(3)
|
2
|
3
|
20
|
36
|
29
|
31
|
35
|
16
|
24
|
29
|
17
|
20
|
|
| Non-Reccuring Items |
0
|
0
|
(0)
|
(2)
|
(2)
|
(2)
|
(0)
|
(3)
|
(2)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
(2)
|
(0)
|
94
|
97
|
95
|
95
|
(1)
|
(15)
|
(1)
|
(1)
|
(0)
|
|
| Gain/Loss on Disposition of Assets |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
4
|
4
|
1
|
0
|
(1)
|
(2)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(6)
|
(8)
|
(7)
|
(5)
|
|
| Pre-Tax Income |
87
N/A
|
94
+8%
|
107
+14%
|
117
+9%
|
137
+17%
|
139
+2%
|
142
+3%
|
152
+6%
|
151
0%
|
162
+7%
|
161
0%
|
153
-5%
|
166
+8%
|
177
+7%
|
201
+14%
|
221
+10%
|
233
+6%
|
253
+8%
|
252
0%
|
262
+4%
|
233
-11%
|
311
+34%
|
286
-8%
|
292
+2%
|
324
+11%
|
224
-31%
|
295
+32%
|
303
+3%
|
310
+2%
|
352
+14%
|
|
| Net Income | |||||||||||||||||||||||||||||||
| Tax Provision |
(10)
|
(11)
|
(13)
|
(14)
|
(17)
|
(17)
|
(16)
|
(17)
|
(16)
|
(22)
|
(26)
|
(24)
|
(27)
|
(24)
|
(20)
|
(23)
|
(22)
|
(22)
|
(13)
|
(13)
|
(15)
|
(25)
|
(22)
|
(24)
|
(22)
|
(10)
|
(33)
|
(35)
|
(31)
|
(37)
|
|
| Income from Continuing Operations |
77
|
82
|
94
|
103
|
120
|
122
|
127
|
134
|
135
|
140
|
136
|
129
|
138
|
153
|
180
|
198
|
211
|
231
|
239
|
249
|
217
|
287
|
264
|
268
|
301
|
214
|
261
|
268
|
279
|
315
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
1
|
1
|
0
|
0
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
78
N/A
|
82
+6%
|
94
+14%
|
103
+9%
|
120
+17%
|
122
+2%
|
127
+4%
|
134
+6%
|
135
+1%
|
140
+3%
|
136
-3%
|
129
-5%
|
138
+7%
|
153
+11%
|
180
+18%
|
198
+10%
|
211
+7%
|
231
+9%
|
240
+4%
|
250
+4%
|
218
-13%
|
287
+32%
|
264
-8%
|
267
+1%
|
301
+13%
|
213
-29%
|
261
+23%
|
268
+3%
|
279
+4%
|
315
+13%
|
|
| EPS (Diluted) |
0.48
N/A
|
0.38
-21%
|
0.51
+34%
|
0.47
-8%
|
0.55
+17%
|
0.56
+2%
|
0.59
+5%
|
0.62
+5%
|
0.62
N/A
|
0.64
+3%
|
0.63
-2%
|
0.6
-5%
|
0.64
+7%
|
0.71
+11%
|
0.81
+14%
|
0.9
+11%
|
0.51
-43%
|
0.56
+10%
|
0.6
+7%
|
0.62
+3%
|
0.54
-13%
|
0.73
+35%
|
0.67
-8%
|
0.68
+1%
|
0.77
+13%
|
0.55
-29%
|
0.66
+20%
|
0.67
+2%
|
0.7
+4%
|
0.79
+13%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
